Key Highlights
- Shares of POET Technologies climbed 108% over the week, reaching an 11-year peak of $15.50 during Friday trading
- The explosive move followed confirmation of a supply agreement with Marvell Technology for 800G optical engines
- Company CFO Thomas Mika disclosed that orders are projected to drive total 2025 revenue beyond $5 million, with shipments beginning in Q3
- By Friday’s closing bell, shares had retreated to $15.10 (+28.84%) amid heavy profit-taking activity
- Market commentator Jim Cramer expressed skepticism, warning the valuation assumes production at scale that doesn’t yet exist
POET Technologies shares reached an intraday peak of $15.50 on Friday before settling at $15.10, marking a single-day advance of 28.84%. The weekly surge of 108% represents the stock’s strongest performance since August 2014.
The surge was driven by official confirmation of a supply partnership with Marvell Technology. Speaking on Stocktwits, CFO Thomas Mika announced that POET had successfully locked in orders from Marvell for its 800G optical engine products.
According to Mika, these orders are anticipated to propel POET’s aggregate 2025 order volume beyond the $5 million threshold. Initial deliveries are scheduled to commence in the third quarter of this year.
The firm is also awaiting decisions from two additional prospective customers: Foxconn and Luxshare. “We expect to hear back from at least one of those,” Mika noted.
Year-to-date, the stock has appreciated 138.55%, bringing its market capitalization to $2.31 billion.
Profit-Taking Triggers Sharp Reversal
The morning rally attracted significant momentum-driven trading activity, propelling shares to their session high. However, once selling pressure emerged, the stock reversed course dramatically.
A short squeeze phenomenon intensified both the upward momentum and subsequent decline. Elevated trading volumes — averaging more than 13.7 million shares daily — magnified price movements in both directions.
Company leadership also took steps to address a short-seller report released earlier in the week. Announcements regarding potential U.S. redomiciling temporarily boosted investor sentiment, though the effect proved short-lived absent additional catalysts.
Sell-side analysts have not significantly adjusted their price objectives following Friday’s action. Technical indicators for the stock continue to signal a buy rating.
Cramer Issues Warning
Jim Cramer, veteran hedge fund manager and Mad Money host, advised investors to exercise caution regarding POET.
“Let’s not get ahead of ourselves with these recent announcements,” Cramer stated. “POET’s got a joint development agreement. They’re not producing this stuff at scale.”
He continued: “The stock’s trading like they’re already in mass production, and that bothers me. Just look at the numbers. POET’s financials make it look more of a science project than a business.”
Cramer highlighted the substantial gap between laboratory-stage technology and commercial-scale production as the primary risk factor investors should consider.
POET’s current confirmed status: orders from Marvell secured, responses from Foxconn and Luxshare awaited, Q3 shipment timeline established.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
